CNS Pharmaceuticals Inc. (CNSP) Fundamentals

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
SHARE INFORMATION
Market Cap$ 9,607,795
Shares Outstanding40,032,481
Float31,359,700
Percent Float78.34%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.54
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions37
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months603,400
Institutional Holdings Percent6.8%
Institutional Sold Previous 3 Months393,301
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.8
Insider Sold Previous 3 Months-
Insider Shares Owned1,139,648
TRADING INFO
52 Week High$ 1.73
52 Week Low$ 0.20
52 Week High Change$ -84.81
21 Day Moving Average$ 0.2332
21 Day Extended Moving Average$ 0.24371
50 Day Moving Average$ 0.2578
50 Day Extended Moving Average$ 0.260016
200 Day Moving Average$ 0.517499
200 Day Extended Moving Average$ 0.58179
10 Day Average Volume218,628
20 Day Average Volume249,499
30 Day Average Volume308,547
50 Day Average Volume624,420
Alpha-0.083421
Beta1.4510
Standard Deviation0.199474
R20.181278
7 Day Price Change$ -0.0102
7 Day Percent Change-4.08%
21 Day Price Change$ 0.0337
21 Day Percent Change16.34%
30 Day Price Change$ -0.03
30 Day Percent Change-11.11%
Month to Date Price Change$ 0.0203
Month to Date Percent Change9.24%
Quarter to Date Price Change$ -0.04
Quarter to Date Percent Change-14.29%
180 Day Price Change$ -0.0932
180 Day Percent Change-27.97%
200 Day Price Change$ -0.3434
200 Day Percent Change-58.86%
Year to Date Price Change$ -0.4624
Year to Date Percent Change-65.83%

CNS Pharmaceuticals Inc. (CNSP) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage-1,628.80
Current Ratio13.80
Leverage Ratio1.10
Quick Ratio11.60
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 1,561,926
Price to Sales0.00
Price to Free Cash-1.20
PE High Last 5 Years0.00
Price To Book0.90
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-91.03
Return on Equity-101.42
Return on Capital-99.14

CNS Pharmaceuticals Inc. (CNSP) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorMaloneBailey, LLP
CEOJohn M Climaco
Emplyoees3
Last AuditUE
CIK0001729427
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2100 West Loop South
Suite 900
Houston, TX 77027
Websitehttps://www.cnspharma.com
Facsimile-
Telephone+1 800 946-9185
Email-
Your Recent History
NASDAQ
CNSP
CNS Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220817 09:48:12